Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00439205 · ClinicalTrials.gov registry record
Oral Margin Spectroscopy Detection Using Optical Spectroscopy
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 58
- Enrollment target
NCT00439205: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00439205 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 58 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00439205 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 58 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to evaluate an imaging technology that may help clinicians see how far an area of pre-cancerous or cancerous tissue extends in the mouth.
Interventions
- DEVICE FastEEM4 System
- DEVICE Multispectral Digital Microscope
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 58 participants |
| Start Date | 2007-02-07 |
| Est. Completion | 2017-10-10 |
What the finished NCT00439205 record still lists
NCT00439205 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 58 participants, a relatively small participant target.
The record links to 0 conditions, and to 2 interventions - of which FastEEM4 System is the first listed.
NCT00439205 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00439205 about?
NCT00439205 is a clinical study titled "Oral Margin Spectroscopy Detection Using Optical Spectroscopy". The goal of this clinical research study is to evaluate an imaging technology that may help clinicians see how far an area of pre-cancerous or cancerous tissue extends in the mouth.
What is the current status of trial NCT00439205?
This trial is currently completed. The enrollment target is 58 participants. The study started on 2007-02-07. Estimated completion is 2017-10-10.
What interventions are being tested in trial NCT00439205?
The interventions under investigation include: FastEEM4 System (DEVICE), Multispectral Digital Microscope (DEVICE).
Who is sponsoring clinical trial NCT00439205?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03587844 · 58 participants · Phase 2
Dosing of Brentuximab Vedotin for Mycosis Fungoides, Sezary Syndrome Patients
- NCT03630991 · 58 participants · Phase 1
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
- NCT03949855 · 58 participants · Phase 2
Belimumab With Rituximab for Primary Membranous Nephropathy
- NCT04069273 · 58 participants · Phase 2
Novel SEQUEnced Immunotherapy With Anti-angiogenesis and Chemotherapy in Advanced gastroesophageaL Adenocarcinoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI